Made in Brockville: Reshoring is all the rage, but 3M’s new N95 plant shows what it’ll take to bring manufacturing back to Canada By Murad Hemmadi
As Alphawave seeks talent and investment in the U.K., some rue a missed opportunity for Canada By Jon Victor
The Canadian IPO’s woman problem: Men named David have better odds than women at taking companies public on the TSX By Aleksandra Sagan
‘It is very personal’: AbCellera’s COVID-19 treatment is saving lives in the U.S. In Canada, it’s sitting in storage. Now the company’s CEO is speaking out By Aleksandra Sagan
What happened at Hubba? How the former Toronto tech darling struggled to turn its profile into profits By Catherine McIntyre
Beyond Bad Blood: Healthtech startup Truvian hopes to succeed where Theranos failed By Aleksandra Sagan
The $35B man: Critics have written off the embattled Canada Infrastructure Bank as ineffectual at best, and a Liberal slush fund at worst. Can new CEO Ehren Cory turn it around? By Martin Patriquin
